XML 42 R30.htm IDEA: XBRL DOCUMENT v3.23.2

Operating Segments (Tables)

6 Months Ended

Jun. 30, 2023

Segment Reporting [Abstract]

Schedule of Segment Reporting Information

The table below presents certain financial information of our operating segments for the three and six months ended June 30, 2023 and 2022 (in thousands):

Schedule of Segment Reporting Information 

Segment Reporting for the Quarter Ended June 30, 2023

															(1)
		Treatment				Services				Segments Total				Corporate (1)				Consolidated Total
Revenue from external customers		$	12,834			$	12,198			$	25,032			$	—			$	25,032
Intercompany revenues			26				17				43				—				—
Gross profit			2,491				2,025				4,516				—				4,516
Research and development			91				7				98				23				121
Interest income			—				—				—				172				172
Interest expense			(23	)			—				(23	)			(24	)			(47	)
Interest expense-financing fees			—				—				—				(24	)			(24	)
Depreciation and amortization			589				89				678				14				692
Segment income (loss) before income taxes			1,356				1,189				2,545				(1,594	)			951
Income tax expense			83				349				432				—				432
Segment income (loss)			1,273				840				2,113				(1,594	)			519
Expenditures for segment assets			293				5				298				—				298	(2)

Segment Reporting for the Six Months Ended June 30, 2023

															(1)
		Treatment				Services				Segments Total				Corporate (1)				Consolidated Total
Revenue from external customers		$	22,428			$	22,711			$	45,139			$	—			$	45,139
Intercompany revenues			230				36				266				—				—
Gross profit			3,743				3,782				7,525				—				7,525
Research and development			158				10				168				52				220
Interest income			—				—				—				298				298
Interest expense			(45	)			(1	)			(46	)			(54	)			(100	)
Interest expense-financing fees			—				—				—				(44	)			(44	)
Depreciation and amortization			1,162				249				1,411				28				1,439
Segment income (loss) before income taxes			1,514				2,132				3,646				(3,216	)			430
Income tax (benefit) expense			(91	)			319				228				—				228
Segment income (loss)			1,605				1,813				3,418				(3,216	)			202
Expenditures for segment assets			1,043				4				1,047				—				1,047	(2)

Segment Reporting for the Quarter Ended June 30, 2022

															(1)
		Treatment				Services				Segments Total				Corporate (1)				Consolidated Total
Revenue from external customers		$	8,393			$	11,062			$	19,455			$	—			$	19,455
Intercompany revenues			—				17				17				—				—
Gross profit			1,563				1,321				2,884				—				2,884
Research and development			59				8				67				13				80
Interest income			—				—				—				29				29
Interest expense			(19	)			3				(16	)			(25	)			(41	)
Interest expense-financing fees			—				—				—				(15	)			(15	)
Depreciation and amortization			381				86				467				13				480
Segment income (loss) before income taxes			364				515				879				(1,789	)			(910	)
Income tax expense			304				43				347				—				347
Segment income (loss)			60				472				532				(1,789	)			(1,257	)
Expenditures for segment assets			373				39				412				—				412	(3)

Segment Reporting for the Six Months Ended June 30, 2022

															(1)
		Treatment				Services				Segments Total				Corporate (1)				Consolidated Total
Revenue from external customers		$	15,872			$	19,498			$	35,370			$	—			$	35,370
Intercompany revenues			—				27				27				—				—
Gross profit			2,201				2,319				4,520				—				4,520
Research and development			124				23				147				29				176
Interest income			—				—				—				40				40
Interest expense			(33	)			2				(31	)			(45	)			(76	)
Interest expense-financing fees			—				—				—				(28	)			(28	)
Depreciation and amortization			752				157				909				27				936
Segment (loss) income before income taxes			(117	)			799				682				(3,514	)			(2,832	)
Income tax benefit			(254	)			(72	)			(326	)			—				(326	)
Segment income (loss)			137				871				1,008				(3,514	)			(2,506	)
Expenditures for segment assets			670				88				758				—				758	(3)

⁽¹⁾ Amounts reflect the activity for corporate headquarters not included in the segment information.

⁽²⁾ Net of financed amount of $107,000 and $157,000 for the three and six months ended June 30, 2023, respectively.

⁽³⁾ Net of financed amount of $0 and $114,000 for the three and six months ended June 30, 2022, respectively.

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482573/350-20-50-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-25

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration